Browsing Tag
TA-TMA
2 posts
Omeros seeks EMA approval for narsoplimab to treat stem cell transplant-related TA-TMA
Omeros Corporation has submitted a Marketing Authorization Application to the EMA for narsoplimab, aiming to treat TA-TMA across Europe. Learn what’s at stake.
Omeros stock skyrockets as narsoplimab improves survival in pivotal TA-TMA trial
Omeros Corporation, a Seattle-based biopharmaceutical company, is making waves after releasing results from its pivotal clinical trial for…